Movers & Shakers: People on the Move
New Director for One Nucleus
One Nucleus, the Cambridge based not-for-profit membership organisation for international life science and healthcare companies, has announced the appointment of Linda Summerton as a Director.
Linda is Chief Executive of Immodulon and a Senior Partner with TranScrip Partners. She has over 25 years’ experience in the global pharmaceutical industry in large pharmaceutical companies, small biotechnology companies, private equity ventures and specialist service provider organisations. She has deep understanding of the needs and interests of the SME life science and healthcare community.
As the CEO of Immodulon, Linda is passionate about supporting smaller companies within the sector ecosystem, and commenting on her appointment said: “Having worked closely with One Nucleus I am very excited about working with the team to support their future objectives. These are challenging times for life sciences and healthcare companies and One Nucleus is extremely well placed to support the sector. I am delighted to have been asked to join the Board and look forward to bringing my experience to the table, to support the team and assist One Nucleus members.”
Jon Green, Chair of One Nucleus commented: “Linda is a great addition to the team. She has a deep understanding of the needs of One Nucleus members, and this coupled with her current interests, particularly as CEO of a growing biotech company make her an ideal Director for One Nucleus”.
Linda worked for 18 years at AstraZeneca, where she held a variety of roles, including project director for Iressa to first registrations in Oncology, Accolate to NDA in asthma, and culminating in being Head of Strategy and Portfolio for the Oncology and Infection Therapy Area Management Team (TAMT).
She was also SVP Portfolio and Project Integration (PPI) at Merck KGaA, based in Darmstadt, leading the portfolio steering committees for Oncology, Cardiovascular and CNS development programmes as well as managing a department of commercial and development personnel.
Latterly Linda became a Senior Partner at TranScrip, a specialist service provider to the pharma and biotech industry, where she leads oncology services and directly supports clients working in oncology. Immodulon is currently her major commitment. Linda has a first degree and PhD from Cambridge UK, and held a NATO post-doctoral Fellowship tenured at the University of California, San Francisco.
The Institute of Economic Affairs has appointed Dr Jamie Whyte as a New Director of Research and Julian Jessop as New Chief Economist.
Julian Jessop becomes the IEA’s Chief Economist in a newly created role. He has thirty years of experience as a professional economist in the public and private sectors, having worked at HM Treasury and most recently as Chief Global Economist at the leading independent consultancy, Capital Economics. He will take up his role on 7th March 2017.
Jamie Whyte holds a Ph.D. from Cambridge University and is former leader of the ACT Party of New Zealand. He will take up his role in mid-April 2017. He takes over the position from Professor Philip Booth, who has taken up a role as Professor of Finance, Public Policy and Ethics at St. Mary’s University, Twickenham. Professor Booth remains at the IEA for one day a week as an Academic Fellow.
The IEA seeks to promote the role of markets in solving economic and social problems, aiming to change the climate of opinion over the long term.
ADE Welcomes New Policy Officer
The Association for Decentralised Energy is delighted to welcome Chris Higby to the team. Chris will take on the role of Policy Officer.
Chris joined the ADE in 2017 and works on the Association’s policy and regulatory development team. Tasked with connecting ADE customers and policymakers, Chris helps develop CHP and DSR markets by ensuring that policy goals and commercial development are aligned so as to favour innovation and growth.
Raised in California, USA, Chris holds a Bachelor of Arts degree in Political Science from Tulane University and a Masters of Business Administration from the University of Southern California. Prior to moving to the UK, he spent 10 years working with the US government, splitting that time evenly as an employee of the US Congress and a corporate energy lobbyist.